NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.16). The firm earned $4.32 million during the quarter, compared to analyst estimates of $6.18 million. View Senseonics' Earnings History.

Senseonics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Senseonics.

Senseonics issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $$20-22 million, compared to the consensus revenue estimate of $$26.62 million.

6 equities research analysts have issued 12-month price targets for Senseonics' stock. Their forecasts range from $1.00 to $2.50. On average, they expect Senseonics' stock price to reach $1.90 in the next twelve months. This suggests a possible upside of 120.9% from the stock's current price. View Analyst Price Targets for Senseonics.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

Media stories about SENS stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Senseonics earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Senseonics.

Some companies that are related to Senseonics include Volpara Health Tech (VHT), Akumin (AKU), Exagen (XGN), Renalytix Ai (RENX), Profound Medical (PRN), Palatin Technologies (PTN), Oncosil Medical (OSL), MaxCyte (MXCT), Yourgene Health (YGEN), Lexagene (LXG), BARD1 Life Sciences (BD1), Sernova (SVA), GeneNews (GEN), Oncimmune (ONC) and SQI Diagnostics (SQD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), CytoDyn (CYDY), Tandem Diabetes Care (TNDM), TransEnterix (TRXC), Novavax (NVAX), Sorrento Therapeutics (SRNE), Tetraphase Pharmaceuticals (TTPH), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD) and Advanced Micro Devices (AMD).

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.86.

Senseonics has a market capitalization of $174.97 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.